Post-approval studies (Phase 4)UnknownNCT00335205
What this trial is testing
A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
Who this might be right for
Bipolar DisorderMajor Depressive Disorder
Sheba Medical Center 60